Pea, F <br/><br/>
Therapeutic drug monitoring-guided high teicoplanin dosage regimen required to treat a hypoalbuminemic renal transplant patient undergoing continuous venovenous hemofiltration.  [electronic resource] 

 -  Therapeutic drug monitoring  Oct 2001 
 - 587-8 p.  digital 
<br/><br/> Publication Type: Case Reports; Letter 
<br/><br/><label>ISSN: </label>0163-4356 
<br/><br/><label>Standard No.: </label>10.1097/00007691-200110000-00013  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-Bacterial Agents--administration & dosage<br/>Cilastatin--pharmacology<br/>Cilastatin, Imipenem Drug Combination<br/>Dose-Response Relationship, Drug<br/>Drug Combinations<br/>Drug Monitoring<br/>Hemofiltration<br/>Humans<br/>Imipenem--pharmacology<br/>Kidney Transplantation<br/>Male<br/>Multiple Organ Failure--complications<br/>Sepsis--complications<br/>Serum Albumin--deficiency<br/>Teicoplanin--administration & dosage